Interferon (INF)-β-1b has a beneficial impact on MRI efficacy measures regarding lesion activity in patients with newly diagnosed multiple sclerosis

Author：

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1611, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β-1b: In Newly Emerging Multiple Sclerosis

By McKeage Kate

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 787-792

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi Montalban Xavier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite

Alemtuzumab shows further benefits over INF-β-1b for RRMS

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Interferon-β-1b: A Review of its Use in Multiple Sclerosis

By Plosker Greg L.

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 67-88

Adis International

Access to resources Recommend Favorite